Manuela Spadea: Celebrating Recognition for Pediatric HSCT Research at EHA 2026
Manuela Spadea, Assistant Professor of Pediatrics at University of Turi, shared a post on LinkedIn:
“Grateful that our European Hematology Association (EHA) 2026 poster was selected as one of the top-scoring abstracts and received a travel grant to attend the Congress in Stockholm.
Presenting and discussing our work on early risk stratification after pediatric allogeneic HSCT was a real pleasure.
This is a setting where fever and inflammation can indicate very different clinical paths, ranging from benign febrile neutropenia to infectious or endothelial-driven transplant-related complications.
Importantly, the research is still underway.
We are refining the analyses to enhance statistical power, improve clinical relevance, and better understand how Pro-ADM can aid in risk-based monitoring and decision-making in pediatric HSCT.
A heartfelt thank you to all the co-authors, participating centers, clinical teams, clinical trial office colleagues, patients, and families who made this collaborative effort possible.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome